Quality Assessment Schemes Program
|
|
- Christine Strickland
- 5 years ago
- Views:
Transcription
1 Quality Assessment Schemes Program
2 ABOUT ESfEQA ESfEQA EQA programs The European Society for External Quality Assessment offers laboratories a wide range of EQA schemes organized in four areas: biochemistry, immunology, microbiology and hematology. The ESfEQA programs for external quality assessment are intended for those who perform laboratory investigations either in their own laboratories or who are responsible for the quality in medical laboratories. About ESfEQA samples and services ESfEQA provides samples and services of high quality, reliability, convenience and flexibility. Quality The suitability of all samples for different technologies is achieved by multidisciplinary approaches to assess the reliability of control materials. All samples are designed for commutability. ESfEQA is accredited according to DIN EN ISO/ IEC 17043: Reliability All fields of activity necessary to provide EQA surveys are streamlined for reliability: production and selection of sample materials, shipment logistics as well as handling electronic data and results. Prior to their use in EQA schemes, samples are carefully selected, thus guaranteeing high and constant sample quality. For timely shipment, ESfEQA works hand in hand with reliable distributors. And finally, participants have full and reliable control over their data. Convenience and flexibility ESfEQA s proficiency testing software features an easy-access web interface which allows participants to submit their results and to retrieve the statistic reports that are displayed directly online. Requests for new method, instrument and reagent codes can be made online. The subscription to any ESfEQA program allows particpants to submit up to three results obtained from a single control set using different devices. Reports are provided online as pdf-files within 3 weeks after the deadline of result submission. Report files can be stored electronically, forwarded and printed. Sample Ordering ESfEQA offers EQA schemes worldwide and cooperates with reliable regional distributors. They are the direct business partners of participants, responsible for the ordering process, invoicing and local shipment of survey samples. ESfEQA offers programs with 2, 4 or 12 surveys per year. In general, programs should be ordered for an entire calendar year. To ensure a cost-effective shipping process, survey samples are shipped semi-annually as long as this frequency is permitted by sample stability. New Programs Based on the feedback of our participants, ESfEQA extends the EQA portfolio continously. Please contact us for further suggestions on new programs. Programs that have not been listed on the ESfEQA ISO accreditation certificate yet are marked in this catalogue as not accredited. Survey Calendar The dates for survey sample ordering, begin of result entry and deadline for result entry are published in this catalogue and on the ESfEQA website (www. esfeqa.eu). Heidelberg, February 2018 ESfEQA GmbH Siemensstraße Heidelberg GERMANY phone +49(0) fax +49(0) info@esfeqa.eu 2
3 CONTENT About ESFEQA 2 Biochemistry Programs Blood Gas and Electrolytes 4 Cardiac Marker 4 Clinical Chemistry 4 Coagulation 5 Drugs of Abuse 5 Ethanol 5 Fecal Occult Blood 5 Glycated Hemoglobin 5 Lipids 6 Qualitative Urine Analysis (Urine stick) 6 Therapeutic Drugs 6 Urine Chemistry 6 Immunology Programs Allergology Inhale Allergens 7 Allergology Food Allergens & Insect Poison Allergens 7 Hormones 8 Specific Proteins 8 Tumor Marker 9 Tumor Marker/ Hormones 9 Microbiology Programs Adenovirus 10 Aspergillus Fumigatus 10 Bacteriology 10 Borrelia 10 Brucella 10 Chagas 11 Chlamydia Pneumoniae 11 Chlamydia Trachomatis 11 Coxsackievirus 11 ECHO-Virus 11 Enterovirus 12 Epstein-Barr Virus 12 Hepatitis A Virus 12 Hepatitis B Virus 12 HTLV I/II 12 Infectious Disease Combination Control 12 Influenza A Virus 12 Influenza B Virus 13 Leptospira 13 Measles 13 Mosquito Transmitted Diseases 13 Parainfluenza Virus 14 Parvovirus B19 14 Q-Fever 14 Respiratory Syncytial Virus 14 Syphilis 14 ToRCH 15 Varicella Zoster Virus 15 Hematology Programs Erythrocyte Sedimentation Rate Alifax 15 Erythrocyte Sedimentation Rate 15 Hemogram 15 BIOCHEMISTRY IMMUNOLOGY MICROBIOLOGY HEMATO- LOGY 3
4 BIOCHEMISTRY PROGRAMS BLOOD GAS AND ELECTROLYTES BG 2 liquid buffered aqueous solution samples (minimum 2 ml). 4 or 12 surveys per year. One sample per survey in monthly program (BG12), two samples per survey in quarterly program (BG4). BIOCHEMISTRY Calcium Chloride Glucose Lactate CARDIAC MARKER pco 2 ph po 2 Potassium Sodium Urea CM Lyophilized samples (minimum 1 ml) of human sera with added analytes of human origin. 4 or 12 surveys per year. One sample per survey in monthly program (CM12), two samples per survey in quarterly program (CM4). BNP CK-MB (mass) CK-MB (activity) Homocysteine Myoglobin NT-proBNP Troponin I Troponin T CLINICAL CHEMISTRY CC Lyophilized samples (5 ml) of human sera with added enzymes and proteins of human origin. 2, 4 or 12 surveys per year. One sample per survey in monthly program (CC12), two samples per survey in quarterly and semiannual program (CC4 and CC2). Albumin ALP Alkaline phosphatase ALT/GPT Amylase Amylase pancreatic* AST/GOT Bilirubin, direct Bilirubin, total Calcium Calcium (ionized) Chloride Cholesterol Cholinesterase* CK Creatinkinase Creatinine Gamma GT Glucose HDL Cholesterol Iron Lactate LDH Lactate Dehydrogenase LDL Cholesterol Lipase Lithium Magnesium Phosphate Potassium Sodium TIBC Total Iron Binding Capacity Total protein Triglycerides Urea Uric acid * These parameters are not accredited according to DIN EN ISO/ IEC 17043:
5 COAGULATION COA Lyophilized samples (1 ml) of human plasma. 4 or 12 surveys per year. One sample per survey in monthly program (COA12), two samples per survey in quarterly program (COA4). aptt (activated Partial Thromboplastin Time) Antithrombin III DRUGS OF ABUSE 2 liquid samples (minimum 1 ml) of filtered human urines with added drugs for qualitative analysis. 4 surveys per year. D-Dimer Fibrinogen PT (prothrombin time) Protein C Protein S DAT BIOCHEMISTRY Acetylmorphine Amphetamines Barbiturates Benzodiazepines Buprenorphine Cannabinoids Cocaine Methadone Opiates Tricyclic Antidepressants ETHANOL ETH 2 liquid samples (minimum 0.5 ml) with added compounds. 4 or 12 surveys per year. One sample per survey in monthly program (ETH12), two samples per survey in quarterly program (ETH4). Ethanol FECAL OCCULT BLOOD FOB 2 liquid or lyophilized samples (minimum 0.5 ml). 2 surveys per year. Human hemoglobin in faeces GLYCATED HEMOGLOBIN GHB Lyophilized samples (minimum 0.5 ml) of hemolysate of human blood. 4 surveys per year. One sample per survey in monthly program (GHB12), two samples per survey in quarterly program (GHB4). HbA1c Hemoglobin 5
6 LIPIDS LIP 2 lyophilized samples (3 ml) of human serum. 4 surveys per year. Apolipoprotein A1 Apolipoprotein B Cholesterol HDL Cholesterol LDL Cholesterol Lp (a) Total Protein Triglycerides BIOCHEMISTRY QUALITATIVE URINE ANALYSIS (URINE STICK) 2 liquid samples (min. 10 ml) of urine preparation of human origin with added preservatives and stabilizers. 4 surveys per year. US Bilirubin Glucose Hemoglobin Ketone bodies Leucocytes Nitrite ph Specific Gravity Total Protein Urobilinogen THERAPEUTIC DRUGS TDM 2 liquid samples (minimum 2 ml) with added compounds. 4 surveys per year. Amikacin Carbamazepine Chinidine Chloramphenicol Digoxin Disopyramide Ethosuximide Gentamicin Lidocain NAPA Paracetamol Phenobarbital Phenytoin Primidone Procainamide Salicylate Theophylline Tobramycin Valproic Acid Vancomycin URINE CHEMISTRY UC 2 lyophilized samples (minimum 5 ml) of urine of human origin with added preservatives and stabilizers. 4 surveys per year. Albumin / Microalbumin Calcium Chloride Creatinine Glucose Magnesium Phosphate Potassium Total protein Sodium Urea Uric acid 6
7 IMMUNOLOGY PROGRAMS ALLERGOLOGY INHALE ALLERGENS AL1 2 liquid samples (minimum 1 ml) of human serum. Analytical parameters (below listed parameters are exemplary): IgE total d 1 derm. pteronyssinus d 2 derm. farinae d 70 acarus siro e 1 cat epithelia e 3 horse epithelia e 5 dog epithelia e 6 guinea pig epithelia e 82 rabbit epithelia e 84 k 82 m 1 m 3 m 6 t 2 t 3 t 4 t 7 hamster epithelia latex penicilinum chrysogenum aspergillus fumigatus alternaria alder birch hazel oak w 1 common ragweed w 2 western ragweed w 6 mugwort w 7 maguerite w 9 ribwort plantain w 20 nettle w 206 camomile ALLERGOLOGY FOOD ALLERGENS & INSECT VENOM ALLERGENS 2 liquid samples (minimum 1 ml) of human serum. AL2 IMMUNOLOGY Analytical parameters (below listed parameters are exemplary): IgE total f 1 egg white f 2 milk f 3 cod f 4 wheat flour f 5 rye flour f 12 pea f 13 peanut f 14 soybean f 17 hazelnut f 23 crab f 24 shrimp f 25 f 31 f 33 f 35 f 37 f 41 f 49 f 48 f 59 f 75 f 76 f 77 tomato carrot orange potato blue mussel salmon onion apple octopus egg yellow α-laktalbumin β-laktoglobulin f 78 casein f 84 kiwi f 85 celery f 91 mango f 92 banana f 218 sweet pepper f 256 walnut g 12 rye i 1 bee venom i 3 wasp venom i 6 cockroach 7
8 HORMONES HOR Liquid or lyophilized samples (minimum 2 ml) of human sera with added analytes of human origin. 4 or 12 surveys per year. One sample per survey in monthly program two samples per survey in quarterly program. Aldosterone AMH Androstendione Calcitonin C-Peptide Cortisol DHEA-S Estradiol Ferritin Folate FSH hcg Human Growth Hormone IgE Insulin LH (Luteinizing Hormone) PTH Progesterone Prolactin SHBG T3, free T3, total T4, free T4, total Testosterone Thyreoglobulin TSH Vitamin B12 Vitamin D IMMUNOLOGY SPECIFIC PROTEINS Liquid (minimum 1 ml) or lyophilized samples (1 ml) of human sera with added analytes of human origin. 4 or 12 surveys per year. One sample per survey in monthly program (SP12), two samples per survey in quarterly program (SP4). SP Albumin Alpha-1-acid glycoprotein Alpha-1-antitrypsin Alpha-2-macroglobulin ASO Beta-2-microglobulin C3 C4 Ceruloplasmin CRP (C-Reactive Protein) Haptoglobin IgA IgE IgG IgM Prealbumin RF Transferrin 8
9 TUMOR MARKER TM Liquid or lyophilized samples (minimum 2 ml) of human sera with added analytes of human origin. 4 or 12 surveys per year. One sample per survey in monthly program, two samples per survey in quarterly program. AFP CEA CA 19-9 CA 125 CA 15-3 Ferritin PSA, total PSA, free TUMOR MARKER/HORMONES TMH Lyophilized sample (minimum 3 ml) of human sera with added analytes. 4 or 12 surveys per year. One sample per survey in monthly program (TMH12), two samples per survey in quarterly program (TMH4). AFP Aldosterone AMH Androstendione CA 125 CA 15-3 CA 19-9 Calcitonin CEA Cortisol C-Peptide DHEA-S Estradiol Ferritin Folate FSH hcg Human Growth Hormone IgE Insulin LH (Luteinizing Hormone) Progesterone Prolactin PSA, free PSA, total PTH SHBG T3, free T3, total T4, free T4, total Testosterone Thyreoglobulin TSH Vitamin B12 Vitamin D IMMUNOLOGY 9
10 MICROBIOLOGY PROGRAMS ADENOVIRUS ADE IgA, IgG and IgM antibodies against Adenovirus ASPERGILLUS FUMIGATUS ASF IgA, IgG and IgM antibodies against Aspergillus fumigatus BACTERIOLOGY BAC 4 lyophilized samples (pure strains and/or mixture of bacteria): 2 for identification and 2 for antibiotic susceptibility testing. 4 surveys per year. This program is not accredited according to DIN EN ISO/ IEC 17043:2010. MICROBIOLOGY Identification (genus and species) Antibiotic susceptibility testing BORRELIA 2 liquid samples (1 ml) of human plasma. 2 surveys per year. BOR IgG and IgM antibodies against Borrelia BRUCELLA IgA, IgG and IgM antibodies against Brucella BRU 10
11 CHAGAS CHA New Program anti-trypanosoma cruzi IgG/IgM CHLAMYDIA PNEUMONIAE CHP 2 liquid samples (1 ml) of human plasma. 2 surveys per year. IgG, IgM, and IgA antibodies against Chlamydia pneumoniae CHLAMYDIA TRACHOMATIS CHT 2 liquid samples (1 ml) of human plasma. 2 surveys per year. IgG, IgM, and IgA antibodies against Chlamydia trachomatis COXSACKIEVIRUS COX MICROBIOLOGY IgA, IgG and IgM antibodies against Coxsackievirus ECHO-VIRUS IgA, IgG and IgM antibodies against ECHO-Virus ECH 11
12 ENTEROVIRUS ENT IgA, IgG and IgM antibodies against Enterovirus EPSTEIN-BARR VIRUS EBV 2 liquid samples (1 ml) of human plasma. 4 surveys per year. anti-ebv VCA IgG + total anti-ebv EBNA-1 IgG + total anti-ebv VCA IgM HEPATITIS A VIRUS HAV 2 liquid samples (1 ml) of human plasma. 4 surveys per year. anti-hav IgG + total anti-hav IgM HEPATITIS B VIRUS HBV MICROBIOLOGY 2 liquid samples (minimum 1 ml) of human plasma. 4 surveys per year. anti-hbs (qual. and quant.) anti-hbc anti-hbe HBsAg (qual. and quant.) HBeAg anti-hbc IgM HTLV I/II HTL 2 liquid samples (1 ml) of human plasma. anti HTLV I/II INFECTIOUS DISEASE COMBINATION CONTROL INF 2 liquid samples (1 ml) of human plasma. 4 surveys per year. anti-hiv 1/2 anti-hcv anti-hbc HBsAg 12
13 INFLUENZA A VIRUS INA IgA, IgG and IgM antibodies against Influenza A Virus INFLUENZA B VIRUS INB IgA, IgG and IgM antibodies against Influenza B Virus LEPTOSPIRA LEP 2 liquid samples (0,5 ml) of human plasma. IgG and IgM antibodies against Leptospira MEASLES 2 liquid samples (1 ml) of human plasma. 2 surveys per year. IgG and IgM antibodies against Measles Virus MEA MICROBIOLOGY MOSQUITO TRANSMITTED DISEASES 4 liquid samples (1 ml) of human plasma. MTD New Program anti-chikungunya Virus IgG/IgM anti-dengue Virus IgG/IgM anti-west Nile Virus IgG/IgM anti-zika Virus IgG/IgM 13
14 PARAINFLUENZA VIRUS PIN IgA and IgG antibodies against Parainfluenza Virus PARVOVIRUS B19 PAR 2 liquid samples (1 ml) of human plasma. 2 surveys per year. IgG and IgM antibodies against Parvovirus B19 Q-FEVER QFE New Program anti-coxiella burnetii Phase I IgG/IgA anti-coxiella burnetii Phase II IgG/IgM MICROBIOLOGY RESPIRATORY SYNCYTIAL VIRUS IgG, IgM, and IgA antibodies against Respiratory Syncytial Virus (RSV) RSV SYPHILIS 2 liquid samples (1 ml) of human plasma. 4 surveys per year. IgG, IgM, antibodies total against Treponema pallidum (qualitative and quantitative*) Non-treponemal lipoid antibodies (qualitative and semi-quantitative)* * This parameter is not accredited according to DIN EN ISO/ IEC 17043:2010. SYP 14
15 ToRCH TORCH 2 liquid samples (1.5 ml) of human plasma. 4 surveys per year. anti-cmv IgG + total (qual. and quant.) anti-cmv IgM anti-hsv 1/2 IgG + total (qual. and quant.) anti-hsv 1/2 IgM anti-rubella IgG + total (qual. and quant.) anti-rubella IgM anti-toxoplasma gondii IgG + total (qual. and quant.) anti-toxoplasma gondii IgM VARICELLA ZOSTER VIRUS VZV 2 liquid samples (1 ml) of human plasma. 2 surveys per year. IgG, IgM, and IgA* antibodies against Varicella Zoster Virus (VZV) * This parameter is not accredited according to DIN EN ISO/ IEC 17043:2010. HEMATOLOGY PROGRAMS ERYTHROCYTE SEDIMENTATION RATE ON ALIFAX ANALYZERS ESRAF 3 liquid samples (about 3 ml) for transmittance measurement related to ESR values in human samples. This program is not accredited according to DIN EN ISO/ IEC 17043:2010. Erythrocyte Sedimentation Rate ERYTHROCYTE SEDIMENTATION RATE ESR 2 liquid samples (2 ml) containing erythrocytes. 4 surveys per year. This program is not accredited according to DIN EN ISO/ IEC 17043:2010. The samples are not suitable for testing on Alifax and Alcor ised instruments. MICROBIOLOGY Erythrocyte Sedimentation Rate HEMOGRAM HEM Liquid samples (minimum 2.5 ml) of whole blood. The samples contain stabilized human red blood cells, white blood cells and platelets of human and/or non-human analogs. 4 or 12 surveys per year. One sample per survey in monthly program (HEM12), two samples per survey in quarterly program (HEM4). HEMATOLOGY HCT (hematocrit) HGB (hemoglobin) MCH (mean corpuscular hemoglobin) MCHC (mean cellular hemoglobin concentration) MCV (mean corpuscular volume) MPV (mean platelet volume) PLT (platelets) RBC (red blood cells) RDW (RBC distribution width) WBC (white blood cells) 15
16 Survey Calendar 2018 Version Date Biochemistry Immunology Microbiology ESR Hemogram Nov Deadline for Ordering (Q1-Q4 of 2018) monthly programs surveys 1-12 quarterly programs surveys 1-4 monthly programs surveys 1-12 quarterly programs surveys 1-4 monthly programs surveys 1-12 quarterly programs surveys 1-4 quarterly program surveys 1-4 monthly program surveys 1-12 quarterly program surveys Begin of Result Entry monthly programs survey 1 monthly programs survey 1 monthly programs survey 1 quarterly program survey 1 Jan Begin of Result Entry monthly program survey 1 29 Deadline for Result Entry quarterly program survey 1 5 Deadline for Result Entry monthly programs survey 1 monthly programs survey 1 monthly programs survey 1 monthly program survey 1 6 Begin of Result Entry monthly program survey 2 quarterly program survey 1 Feb 18 9 Deadline for Ordering (Q2-Q4) monthly programs surveys 4-12 quarterly programs surveys 2-4 semi-annual programs surveys Begin of Result Entry monthly programs survey 2 quarterly programs survey 1 monthly programs surveys 4-12 quarterly programs surveys 2-4 semi-annual programs surveys 1-2 monthly programs survey 2 quarterly programs survey 1 monthly programs surveys 4-12 quarterly programs surveys 2-4 semi-annual programs surveys 1-2 monthly programs survey 2 quarterly programs survey 1 quarterly program surveys 2-4 monthly program surveys 4-12 quarterly program surveys Deadline for Result Entry monthly program survey 2 quarterly program survey 1 20 Begin of Result Entry monthly program survey 3 Mar 18 5 Deadline for Result Entry monthly programs survey 2 quarterly programs survey 1 monthly programs survey 2 quarterly programs survey 1 monthly programs survey 2 quarterly programs survey 1 12 Begin of Result Entry monthly programs survey 3 monthly programs survey 3 monthly programs survey 3 monthly program survey 3 Apr 18 3 Deadline for Result Entry monthly programs survey 3 monthly programs survey 3 monthly programs survey 3 9 Begin of Result Entry monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 quarterly program survey 2 16 Begin of Result Entry monthly program survey 4 23 Deadline for Result Entry quarterly program survey 2 30 Deadline for Result Entry monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 monthly programs survey 4 quarterly programs survey 2 semi-annual programs survey 1 monthly program survey 4 7 Begin of Result Entry monthly programs survey 5 monthly programs survey 5 monthly programs survey 5 monthly program survey 5 quarterly program survey 2 9 Deadline for Ordering (Q3-Q4) monthly programs surveys 7-12 quarterly programs surveys 3-4 monthly programs surveys 7-12 quarterly programs surveys 3-4 monthly programs surveys 7-12 quarterly programs surveys 3-4 quarterly program surveys 3-4 monthly program surveys 7-12 quarterly program surveys 3-4 May Deadline for Result Entry monthly program survey 5 quarterly program survey 2 28 Deadline for Result Entry monthly programs survey 5 monthly programs survey 5 monthly programs survey 5 28 Begin of Result Entry monthly program survey 6 Nov 17 Jan 18 Feb 18 Mar 18 Apr 18 May 18 16
17 Jun 18 Dez 15 Jul 18 Dez 15 Aug 18 Sep 18 Oct 18 Nov 18 Dec 18 C Date Biochemistry Immunology Microbiology ESR Hemogram 4 Begin of Result Entry monthly programs survey 6 monthly programs survey 6 monthly programs survey 6 11 Deadline for Result Entry monthly program survey 6 25 Deadline for Result Entry monthly programs survey 6 monthly programs survey 6 monthly programs survey 6 9 Begin of Result Entry monthly programs survey 7 quarterly programs survey 3 monthly programs survey 7 quarterly programs survey 3 monthly programs survey 7 quarterly programs survey 3 quarterly program survey 3 16 Begin of Result Entry monthly program survey 7 quarterly program survey 3 23 Deadline for Result Entry quarterly program survey 3 30 Deadline for Result Entry monthly programs survey 7 quarterly programs survey 3 monthly programs survey 7 quarterly programs survey 3 monthly programs survey 7 quarterly programs survey 3 monthly program survey 7 6 Begin of Result Entry monthly programs survey 8 monthly programs survey 8 monthly programs survey 8 monthly program survey 8 8 Deadline for Ordering (Q4) monthly programs surveys quarterly programs survey 4 semi-annual programs survey 2 monthly programs surveys quarterly programs survey 4 semi-annual programs survey 2 monthly programs surveys quarterly programs survey 4 semi-annual programs survey 2 quarterly program survey 4 monthly program surveys quarterly program survey 4 20 Deadline for Result Entry monthly program survey 8 quarterly program survey 3 27 Deadline for Result Entry monthly programs survey 8 monthly programs survey 8 monthly programs survey 8 27 Begin of Result Entry monthly program survey 9 4 Begin of Result Entry monthly programs survey 9 monthly programs survey 9 monthly programs survey 9 10 Deadline for Result Entry monthly program survey 9 24 Deadline for Result Entry monthly programs survey 9 monthly programs survey 9 monthly programs survey 9 8 Begin of Result Entry monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 quarterly program survey 4 15 Begin of Result Entry monthly program survey Deadline for Result Entry quarterly program survey 4 29 Deadline for Result Entry monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 monthly programs survey 10 quarterly programs survey 4 semi-annual programs survey 2 monthly program survey 10 5 Begin of Result Entry monthly programs survey 11 monthly programs survey 11 monthly programs survey 11 monthly program survey 11 quarterly program survey 4 14 Deadline for Ordering (Q1-Q4 of 2019) monthly programs surveys 1-12 quarterly programs surveys 1-4 monthly programs surveys 1-12 quarterly programs surveys 1-4 monthly programs surveys 1-12 quarterly programs surveys 1-4 quarterly program surveys 1-4 monthly program surveys 1-12 quarterly program surveys Deadline for Result Entry 26 Deadline for Result Entry monthly programs survey 11 monthly programs survey 11 monthly programs survey 11 monthly program survey 11 quarterly program survey 4 27 Begin of Result Entry monthly programs survey 12 monthly programs survey 12 monthly programs survey 12 monthly program survey Deadline for Result Entry monthly program survey Deadline for Result Entry monthly programs survey 12 monthly programs survey 12 monthly programs survey 12 Jun 18 Jul 18 Aug 18 Sep 18 Oct 18 Nov 18 Dec 18 17
18 GENERAL TERMS FOR THE PARTICIPATION IN EXTERNAL QUALITY ASSESSMENT SURVEYS OF ESFEQA Status February Participation The participation in the external quality assessment (EQA) surveys of ESfEQA is open to anyone who performs laboratory tests in their own practice or in a managed medical laboratory. The following conditions for participation apply. 2. Consent to conditions of participation By registering with ESfEQA GmbH, the participant agrees to these general terms and conditions of participation. 3. Assignment of services Individual parts of EQA schemes (e.g. pretesting of values, packaging and shipping) may be assigned to subcontractors. ESfEQA is responsible for the work of the subcontractors. 4. ESfEQA catalog The ESfEQA portfolio of offered EQA schemes and the analytes contained in the individual programs are described in the ESfEQA catalog. Depending on the availability of samples and the number of participants ESfEQA reserves the right, not to offer the entire spectrum of analytes for each EQA survey or sample. 5. Schedule The schedule is published in the catalog and on the ESfE- QA website. It contains the binding deadlines for ordering, the testing period, and the deadline for result submission. After the deadline for ordering there is no entitlement for the acceptance of orders. Results have to be submitted to ESfEQA electronically or by fax-form until the closing date. The calendar date refers to the time zone at the place of business of ESfEQA in Heidelberg, Germany (GMT +1). 6. Cancelation of EQA surveys ESfEQA reserves the right to cancel or postpone EQA surveys. This information will be provided to participants before the originally planned shipping date of the samples. In this case, ESfEQA tries to offer an alternative date in a timely manner. 7. Registration For the participation in ESfEQA EQA surveys a registration is required. This can be done online, or the necessary information can be provided to ESfEQA in written form. The following information is required: laboratory name, name of the organization/hospital, name of participant, number of analytical devices, and address. 8. Ordering of samples The distribution of ESfEQA EQA surveys is usually carried out by international distributors. If there is no distributor available in the participant's region, sales can be carried out directly by ESfEQA. The ordering process between participants and distributors is the responsibility of the parties involved. As a rule, an EQA programme is ordered for a full calendar year. Orders placed during the year generally include the survey samples up to the end of the current calendar year. 9. Homogeneity and stability of EQA samples The EQA survey samples selected by ESfEQA were examined and evaluated with regard to homogeneity and stability. 10. Designation of EQA samples The EQA samples can be distinguished by their identifier. The identifier consists of the short name of the program, the year of the survey, the survey number and an index, when several samples are provided in a single survey. Thus, the sample with the labeling CM4_2018_01_a belongs to the quarterly program Cardiac Marker (CM4) in the year 2018 and is sample a of the first survey. Samples with the same designation are not necessarily identical, i. e. different results can be measured despite the same designation. ESfEQA makes the correct allocation to the original batch and thus to the target values. 11. Shipping of EQA samples Shipping of the EQA samples takes place by postal or parcel service until the dates published in the catalog. Due to governmental restrictions, or insufficient stability, sample shipping of individual EQA programs to specific countries may be excluded. 12. Instructions for Use Instructions for Use are provided to the participants for each EQA survey on the ESfEQA website ( eu). A printout of the Instructions for Use is usually enclosed with the sample package. The Instructions for Use include instructions for the preparation of the samples, sample stability and the deadline for submission of results. 13. Use of EQA samples EQA samples are to be handled like patient samples and measured in the same way as routine samples according to the instructions of the instrument and reagent manufacturers. They may only be used for the purpose of participating in an EQA survey and may not be used in a misappropriated manner. Generally, the usual precautions in the laboratory for potential hazardous samples apply for the EQA samples. In general, the usual precautionary measures in the laboratory for potentially infectious samples apply to EQA samples. 14. Submission of survey results Where applicable the submission of the measured values by the participant includes, in addition to the actual measured value, the method used, the instrument used and the reagent used. The input mask in the evaluation software application TEQA used by ESfEQA predetermines the required information for each EQA program. A list of methods, instruments and reagents is provided in the configuration area. If the method, instrument or reagent used for the measurement by the participant is not included in this selection list, participants communicate this to ESfEQA through the input mask and uses his/her own method, instrument and reagent. He or she can use these specifications directly to enter his or her test results. The selection of method, instrument and reagent as well as the submission of results are to be transmitted through the web-application TEQA. Participants receive the login data required for the entry of results from ESfEQA. The password consists of at least 8 characters, of which at least 2 are special characters. User name and password are to be treated confidentially by the participant. As alternative to the result submission via the web-applica- 18
19 tion TEQA, results can be submitted using forms, that can be sent to ESfEQA either by or Fax ( ). The corresponding forms that are specific for each EQA program and survey are provided on the ESfEQA website. ESfEQA evaluates all survey results that are submitted by the participants in due time. For loss or late arrival of his/ her data the participant bears the risk. There is no claim for data assessment of test results arrived late. The participant bears the risk of loss of or delayed arrival of his or her data upon sending. There is no entitlement to an evaluation of late examination results. Quantitative values are generally indicated with a value and a unit. The choice of the number of indicated decimal places is up to the participant. Specifications such as < measuring range or < 100 are not valid. If the analyzer system displays such values, they must be interpreted by the participant, e. g. as 0 or as an indication of the value of the lower measuring range. For results above and beyond the measuring range, the sample can be diluted (if recommended for individual applications) or reported as upper measuring range. Several units are usually available for entering quantitative results. The units are converted into the standard unit used by ESfEQA. This standard unit is also used for creating reports. Laboratories are obliged to treat their results confidentially and not to pass them on to third parties until the EQA survey report has been received. If ESfEQA becomes aware of the passing on or falsification of results or the collusion between participants, ESfEQA reserves the right to exclude those concerned from further participation in EQA survey conducted by ESfEQA as well as to exclude the issuance of reports. 15. Number of results per participant For each EQA sample and analyte, up to 3 values per participant can be submitted. The values have to be determined by different analytical devices that are independent from each other. 16. Correction of transmitted results Once the results have been submitted via the web-application TEQA, it is no longer possible for the participant to make any changes. If faulty values are detected by the participant, he/she can inform ESfEQA in written form until the deadline of result submission by specifying the reason. ESfEQA may change the information after checking and accepting the change request. The same applies to results sent by or fax. 17. Evaluation of EQA results For each analyte of ESfEQA EQA surveys, the type of target value determination and the acceptance criterion are determined in advance. For quantitative parameters, the target value is usually the consensus value. This value is calculated according to ISO/IEC 13528:201505' Statistical methods for use in proficiency testing by interlaboratory comparisons' using robust statistics. Qualitative samples are thoroughly tested with different analytical systems before being used as control material, thereby setting the target value. System-specific differences are taken into account where appropriate and possible. The broadest possible distinction is made according to the method, instrument and reagent used (M, I, R group). The minimum number of results of an evaluation group is 5 values. If this number is not reached in the survey, the individual result has to be compared to the robust mean of the next larger group that can be evaluated. Usually, this is the group consisting of participants using the same method (M group) or the general group containing the results of all participants. The definition of the evaluation group is documented in the report. The maximum permissible ranges of the target value of quantitatively determined analytes are defined in advance and can be retrieved from the ESfEQA website. The permissible range for each analyte is derived from its medical relevance as well as the reference interval. In the report display, the upper limit of the permissible range corresponds to a z-value of 3 and the lower limit to a z-value of Survey reports In general, the participants will be provided with reports electronically via the TEQA web-application within three weeks after the deadline for submission of the results. The reports include the results submitted by the participant and their assessment compared to the target values. The data is displayed both in tabular form and as a graphic (e. g. Histogram, Shewart chart, Youden plot). The reports are intended for external quality assurance of laboratories. They may not be published, passed on or used for purposes other than quality assurance without the written consent of ESfEQA. 19. Certificates Participants receive a certificate of participation for each EQA program they participate in. In addition, the participants receive a certificate for the parameters for which they have met the specified performance criteria in the respective EQA survey. Both certificates are made available to the participants via the TEQA web-application. The certificates are issued simultaneously with the reports. 20. Loss and damage of EQA test material In the event of loss of or damage to the sample material, ESfEQA shall, if possible and to the extent that an immediate complaint has been made, replace the sample material by sending replacement samples without acknowledging any claims. However, the contract is fulfilled on the date of dispatch of the original sample material. 21. Complaints After receipt of an EQA survey report, a complaint can be made within a period of 4 weeks. After expiry of this period, the participant's claims on the basis of a reclamation are excluded. In the event of a justified complaint, there is a claim for reimbursement of the amount paid for the EQA survey or for the conduction of a substitute EQA survey. It is for ESfEQA to deciding on one of the two options. ESfEQA GmbH does not reimburse any costs incurred for reagents, time expenditure etc. unless ESfEQA GmbH is liable in accordance with paragraph 2 of these General Terms and Conditions for Participation. 22. Warranty ESfEQA shall only be liable for damages of any kind in the case of intent and gross negligence if the other prerequisites for claims are met. In all other respects, liability for damages of any kind, regardless of the basis of claim, including liability for culpa in contrahendo, is excluded. 23. Confidentiality Individual EQA data is kept confidential. It is only known to the corresponding participant, his/her distributor and ESfE- QA employees. ESfEQA collects, processes and uses personal data of the participant only to the extent necessary for the performance of EQA surveys, the preparation of the reports and for the purpose of quality assurance. This includes the forwarding of the data identifiable by subscriber and device number for quality assurance measures to the respective manufacturer of the analytical systems (device and reagent). 19
20 SCIENTIFIC ADVISORS Prof. Dr. Carl-Erik Dempfle, Mannheim, Germany Dr. med. Reno Frei, Basel, Switzerland Prof. Dr. Henri Wallaschofski, Erfurt, Germany Prof. Dr. Wolfgang Herrmann, Homburg, Germany Prof. Dr. Markus Herrmann, Bolzano, Italy COMPANY INFORMATION ESfEQA GmbH CEO: Oliver Bošnjak Head of Operations: Dr. Dieter Groche Address: Siemensstraße Heidelberg GERMANY Phone: +49(0) Fax: +49(0) Internet: EN-ES-C-I-KA
Annex to the Accreditation Certificate D-EP according to DIN EN ISO/IEC 17043:2010
Deutsche Akkreditierungsstelle GmbH Annex to the Accreditation Certificate D-EP-19851-01-00 according to DIN EN ISO/IEC 17043:2010 Period of validity: 10.04.2017 to 21.01.2021 Holder of certificate: ESfEQA
Annex to the Accreditation Certificate D-EP according to DIN EN ISO/IEC 17043:2010
Deutsche Akkreditierungsstelle GmbH Annex to the Accreditation Certificate D-EP-19851-01-00 according to DIN EN ISO/IEC 17043:2010 Period of validity: 24.08.2018 to 21.01.2021 Holder of certificate: ESfEQA
Quality Assessment Schemes Program
Quality Assessment Schemes Program 2018 1 ABOUT ESfEQA ESfEQA EQA programs The European Society for External Quality Assessment offers laboratories a wide range of EQA schemes organized in four areas:
Quality Assessment Schemes Program 2017/18
Quality Assessment Schemes 2017/18 1 ABOUT ESfEQA ESfEQA EQA programs The European Society for External Quality Assessment offers laboratories a wide range of EQA schemes organized in four areas: biochemistry,
SCOPE OF ACCREDITATION TO ISO/IEC 17043:2010
SCOPE OF ACCREDITATION TO ISO/IEC 17043:2010 BIO-RAD LABORATORIES 9500 Jeronimo Road Irvine, CA 92618-2017 Regulatory Phone (Elizabeth Platt): 949 598-1285 US Product Info/Sales: Phone: (800) 224-6723,
WSLH. Calibration Verification/ Linearity Products. roficiency. esting. Products provided in partnership with:
WSLH PT roficiency esting Calibration Verification/ Linearity Products Products provided in partnership with: www.wslhpt.org 800-462-5261 PTService@slh.wisc.edu General Chemistry Ammonia/Ethanol - 5 x
Types of target values, acceptable ranges
Types of target values, acceptable ranges As the differential of rounding, maximum 1 percent point deviation is allowed from the maximum acceptable range. 100. Clinical chemistry (wet) 1. Calcium RMV 10
GRADING CRITERIA for CMS Regulated Analytes
CLIA '88 AND GRADING The Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) were established by the federal government (CMS) to regulate clinical laboratories and proficiency test providers
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS. External Quality Assurance Services
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS External Quality Assurance Services Table of Contents About Bio-Rad EQAS EQAS Program Overview.... 3 Online EQAS Resources... 4 Submitting
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS. External Quality Assurance Services
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS External Quality Assurance Services Participate in an Internationally Recognized Quality Assessment Program Bio-Rad EQAS programs are fully
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS. External Quality Assurance Services
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS External Quality Assurance Services Participate in an Internationally Recognized Quality Assessment Program Bio-Rad EQAS programs are fully
Daily Quality Control Calibration Verification / Linearity. Quality control made easy. Product Information
Daily Quality Control Calibration Verification / Linearity Quality control made easy. Product Information AUDIT MicroControls Making life in the lab easier. AUDIT provides value to customers through high-quality
Specimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
Specimen Collection Requirements
The following is a job aid listing the specimen collection requirements for laboratory testing at Colchester East Hants Health Center. Specimens must be accompanied by the Patient Information Form G09.
1. Purpose 1.1. To define testing locations, schedule and order priority for each test performed in the core laboratory.
Department Of Pathology GEN.1017.03 Integrated Test Schedule Version# 5 Department Specimen Processing POLICY NO. 1938 PAGE NO. 1 OF 6 Printed copies are for reference only. Please refer to the electronic
External Quality Assurance Services EQAS. Participate in an internationally recognized quality assessment program
External Quality Assurance Services EQAS Participate in an internationally recognized quality assessment program Bio-Rad EQAS programs are fully accredited to help meet the regulatory needs of today's
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS. External Quality Assurance Services
Bio-Rad Laboratories EXTERNAL QUALITY ASSURANCE SERVICES EQAS External Quality Assurance Services Table of Contents About Bio-Rad EQAS EQAS Program Overview.... 3 Online EQAS Resources... 4 Submitting
Controls & Calibrators. Disease Quality Controls
Controls & Calibrators Infectious Disease Quality Controls Infectious Disease Quality Controls A broad selection of controls designed to monitor assay precision of hepatitis, retrovirus, sexually transmitted
You will receive an Advance Shipment Notice (ASN), which reminds you of upcoming shipments and test events, before
2015 Test Event Calendar The following Test Event Calendar applies for all Programs in this section. The number of shipments of sample sets is indicated in the program description for each Program. You
SydPath Reference Intervals for Clinical Trials (Contract Pathology Unit) Unauthorised Copy
HAEMATOLOGY APTT 1 150 M 25 35 sec APTT 1 150 F 25 35 sec Basophils Cord 2 weeks M 0.0 0.4 10^9/L Basophils Cord 2 weeks F 0.0 0.4 10^9/L Basophils 2 wks 3 mths M 0.0 0.2 10^9/L Basophils 2 wks 3 mths
Hamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE
CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE Croatian Centre for Quality Assessment in Laboratory Medicine Dear colleagues, Boskoviceva 18, 10000 Zagreb Croatia Tel/Phone & Fax: +385
Hamilton Regional Laboratory Medicine Program
Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, 2007. of Review: August 2009 of Review: December 2011;
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
JAJ International, Inc./LuSys Laboratories, Inc.
JAJ International, Inc./LuSys Laboratories, Inc. 10054 Mesa Ridge Court, Suite #120 San Diego, California 92121 USA Tel: 1(858) 866-0788, Fax: 1(858) 866-1688 Email: info@jajinternational.com Website:
CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)
ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts 01886 (800) 665-2575 MICROBIOLOGY Bacteriology Aerobic Culture and Identification Antibiotic Susceptibility Testing Direct Antigen Detection Gram Stain
Minimum Whole Blood Volumes for Microcollection Tubes for Neonates, Pediatrics, Patients less than 45 kg (100 lb) and Difficult Collections
The following table outlines the minimum whole blood volume that must be drawn into a microcollection tube (unless otherwise stated) for an individual test on a neonate, pediatric, patient weighing less
BASIC METABOLIC PANEL
Update 2/12/2018 BASIC METABOLIC PANEL CPT 80048 Stability: 3 days at 15-25 C; 7 days at 2-8 C; > 7 days at -70 C Colorimetric Assay, Rate reaction, ISE Components: BUN, Calcium, Chloride, CO2, Creatinine,
cobas c 501 analyzer and cobas c 311 analyzer Within Run Imprecision Guidelines
cobas c 501 analyzer and cobas c 311 analyzer General Information How to use these guidelines Unless otherwise indicated, the data presented is the same for both the cobas c 501 analyzer and the cobas
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
Bio-Rad Laboratories EQAS. External Quality Assurance Services
Bio-Rad Laboratories EXternal QUALITY ASSURANCE SERVICES EQAS External Quality Assurance Services Bio-Rad Laboratories EXternal QUALITY ASSURANCE SERVICES Participate in an internationally recognized quality
TEST LIST SAMPLE REQUIREMENT. 1 ml serum None
ALBUMIN TEST NAME ALKALINE PHOSPHATASE ALLERGY PROFILE, FOOD 30 allergens ALLERGY PROFILE, INHALANT 30 Allergens ALT AMYLASE ANA ANTI- TG ANTI-GLIADIN IGG ANTI-GLIADIN IGA ANTI-HBS ANTI-HCV ANTI-TPO APOLIPOPROTEIN
SPECTRA EAST, INC. Rockleigh, NJ
A2LA has accredited SPECTRA EAST, INC. Rockleigh, NJ for technical competence in the field of Medical Testing This laboratory is accredited in accordance with the recognized International Standard ISO/IEC
ISO 15189:2012 Internationally-Recognized Accredited Laboratory. SPECTRA EAST, INC. Rockleigh, NJ
ISO 15189:2012 Internationally-Recognized Accredited Laboratory A2LA has accredited SPECTRA EAST, INC. Rockleigh, NJ for technical competence in the field of Clinical Testing This laboratory is accredited
QUALITY CONTROL. Linearity Sets
QUALITY CONTROL Linearity Sets The new Acusera Linearity Sets have been designed with convenience in mind, helping you to easily meet CLIA requirements for calibration verification and assessment of linearity.
CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE
CROATIAN SOCIETY OF MEDICAL BIOCHEMISTRY AND LABORATORY MEDICINE Croatian Centre for Quality Assessment in Laboratory Medicine Dear colleagues, Boskoviceva 18, 10000 Zagreb Croatia Tel/Phone & Fax: +385
ELISA. AccuDiag Autoimmune Diseases and Others. ANA Screen Qualitative ~135 min 90.4% 100%
/ AccuDiag Autoimmune Diseases and Others ANA Screen 5102-2 96 ~135 min 90.4% 100% ENA Profile-6 (Sm/RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) 2506-2 96 ~ 60 min 96% 100% ENA Combined Screen (6 antigens) Sm/RNP,
Thyroid Care & Diagnostic Centre
Thyroid Care & Diagnostic Centre Laboratory Test List DEPARTMENT OF CLINICAL PATHOLOGY BLOOD : CBC HCT/ PCV Hb, TC, DC & ESR MCV CE MCH PC MCHC MP Reticulocyte count PBF LE Cell Hb-Electrophoresis Protin
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
Bead Chemiluminescense IMMULITE 2000, 2000 XPI & 2500
Bead Chemiluminescense IMMULITE 2000, 2000 XPI & 2500 For internal use only / Copyright Siemens AG 2006. All rights reserved. المانھای مھم در روشھای کميلومينسانس: کميلومينسانسر مرحله جداسازی.1.2 Page 2
Alaska Native Medical Center Anchorage, AK
ANMC Lab Test Requirements Key: Room Temp (20-25C), Refrigerated (2-8C), (-15 to -25C), Hr (Hours), D (Days), W (Weeks), Mo (Months), Yr (Years). Basic Processing Instructions: Centrifuge all blood specimens
Please contact the Client Services Team if you require further information.
Reference ranges are quoted on all reports where appropriate for the test carried out. The reference range and reporting units, including any interpretive information, is specific to the methodology used
ACCREDITATION DOCUMENT
Accreditation No: Awarded to Dow Diagnostic Reference and Research Laboratory (DDRRL), Dow University of Health Sciences Suparco Road Gulzar e Hijri KDA Scheme-35, Karachi, Pakistan. The scope of accreditation
Specific Panels. Celiac disease panel. Pancreas Panel:
Specific Panels Celiac disease panel Anti Endomysium IgA Anti Endomysium IgG Anti Gliadin IgA Anti Gliadin IgG Anti Transglutaminase IgA Anti Transglutaminase IgG Total IgA Total IgG Stool analysis +Sudan
Controls & Calibrators Clinical Chemistry
Controls & Calibrators Clinical Chemistry Clinical Chemistry Controls & Lipids Clinical Chemistry and lipid quality controls have been manufactured from true human serum to ensure they perform the same
Premium Controls for Immunochemistry
Bio-Rad Laboratories Quality Control Premium Controls for Immunochemistry Powerful Combinations for Productive QC Solutions Quality Control Consolidated Controls Address the Complex Needs of Your Multi-disciplined
ICL Integrative Laboratory Services Test Menu Contact ICL Client Care x300
Alletess Food Sensitivity Fingerstick 96 Foods IgG with or without Wellness Program 184 Foods IgG with or without Wellness Program Alletess Food Allergy/Sensitivity Serum 96 Foods IgG with or without Wellness
BC Biomedical Laboratories Adult Reference Ranges
BC Biomedical Laboratories Adult s Name Age 25 OH VITAMIN D Blood B 0-100 nmol/l Interpretation: < 25 Deficient 25-74 Insufficient 75-199 Sufficient > 200 Toxic 5HIAA (CALC) Urine B 0-100
Authorised: JSWoodford, Lead of Speciality. Biochemistry Reference Intervals, October Page 1 of 5
AFP All All < 15 ug/l Albumin All 0-3M 25-40 g/l Albumin All 3-12M 32-45 g/l Albumin All 1-70Y 34-48 g/l Albumin All >70Y 32-46 g/l Alk Phos All 0-10Y 80-350 U/L Alk Phos M 10-14Y 45-400 U/L Alk Phos F
Rapid Laboratories In House Tests
Electrolytes CL CL (CHLORIDE) Electrolytes CO2 CO2 (BICARBONATE) Electrolytes K K (POTASSIUM) Electrolytes NA NA (SODIUM) Basic Metabolic Panel (BMP) GLU GLU (GLUCOSE) Basic Metabolic Panel (BMP) CA CA
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Biochemistry Department Poole Hospital Longfleet Road Poole BH15 2JB Contact: Dr Fergus Jack Tel: +44 (0) 1202 442 497 E-Mail: Fergus.jack@poole.nhs.uk
NEW RCPCH REFERENCE RANGES-
s vary between populations and age groups and it is important to always check the reference Haematology: Haemoglobin Male 130 175 g/l 0 6 days 145-220 g/l Female 115 165 g/l 7 days 140-186 g/l 8 days 3
LABORATORY NORMAL RANGES. Prepared by Date Adopted Supersedes Procedure # / Dated William T. Pope, PhD and
Prepared by Date Adopted Supersedes Procedure # / Dated William T. Pope, PhD and 3-31-09 Normal Ranges / 12-30-08 Christy O Brien, MT (ASCP) CHEMISTRY Acetone None detected Albumin, g/dl 3.5-5.0 Adult
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
Analyte Specimen Demographic Reference Range Units
Acetone Negative titer Alanine aminotransferase (ALT/SGPT) 10-49 U/L Albumin 3.2-4.8 g/dl Alcohol < 10 Alpha-fetoprotein (AFP) < 1.3-8.1 ng/ml Alkaline phosphatase 0 7 days 7 30 days 1 3 3 6 6 12 1 3 3
Tests by age. specific inherited syndromes and inflammatory bowel disease
Prevention Guidelines for Men 18 49 Tests by age Screening Who needs it Tests Colorectal cancer Men diagnosed with specific inherited syndromes and inflammatory bowel disease ANCA p+c ASCA IgA ASCA IgG
Saskatchewan ND Price List
Saskatchewan ND Price List Note: There is a $55 per requisition documentation fee. Prices valid only in Saskatchewan. PANEL Healthy Living Assessment Panel $115.00 Enhanced Healthy Living Assessment Panel
PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8
Clinical Laboratory Improvement Amendments (CLIA) Brochure # 8 PROFICIENCY TESTING DOs and DON Ts NOTE: Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Biochemistry Department University Hospital of North Durham Durham County Durham DH1 5TW Contact: Dr Tim Lang Tel: +44 (0) 191 333 2694 Fax:
Third Party Controls for Your Dade Behring Systems
Bio-Rad Laboratories Q U A L I T Y C O N T R O L Third Party Controls for Your Dade Behring Systems The Complete QC Solution from Bio-Rad Laboratories Bio-Rad has the control you need for your Dade Behring
Current September 2017
1 Lab Service PRICE 87077 PATHOGEN ID 6 87088 PRESUMP ID, URINE CULTUR 6 87140 HSV CULTURE TYPING 13 87186 MIC (MIN INHIB CONC) 7 AMYLASE, SERUM 3 ANA SCREEN/RFX TITER AND DSDNA 4 ANA SCREEN/RFX TITER/COMPREHEN
Tables of Normal Values (As of February 2005)
Tables of Normal Values (As of February 2005) Note: Values and units of measurement listed in these Tables are derived from several resources. Substantial variation exists in the ranges quoted as normal
NORTH SHORE - LONG ISLAND JEWISH HEALTH SYSTEM LONG ISLAND JEWISH MEDICAL CENTER DEPARTMENT OF LABORATORY MEDICINE REFERENCE RANGES
S A2 COLUMN 0D 2.0-3.5 2.0-3.5 % ACETAMINOPHEN 0D 5-25 5-25 > 150 ug/ml > 50 ug/ml 12 hour post ingestion > 100 ug/ml 8 hour post ingestion > 200 ug/ml 4 hour post ingestion ACTIVATED PROTEIN C RESIS 0D
ENROLLMENT CONFIRMATION
Step 1: Please review the Facility/Contact information. If any of the information is incorrect, please make the appropriate changes below: Facility/Contact Phone: (850)474-3660 Fax: (850)474-3659 6431
Proficiency Testing LABFACTS Requirements for good laboratory practice and COLA Laboratory Accreditation programs are underlined.
Proficiency Testing LABFACTS 8 INTRODUCTION Proficiency testing (PT) is an important aspect of an overall quality assurance program. PT serves as an external check to verify the accuracy of a 's results
GENERAL INFORMATION CLINICAL LABORATORY PHONE DIRECTORY
GENERAL INFORMATION CLINICAL LABORATORY PHONE DIRECTORY SECTION PHONE NUMBER Clinical Pathologist 431-5888 Laboratory Main Laboratory Administrative Director Janis Nall Accessioning/Client Services Section
Program Analyte Unit Target Limit Absolute SD %
Andrology Sperm Count 1.0E06/mL Peer Group Mean SD 2 Sperm Morphology % normal Peer Group Mean SD 2 Sperm Viability % viable Peer Group Mean SD 2 Endocrinology Cortisol µg/dl Peer Group Mean % of Target
MEMORANDUM. These reference ranges are effective immediately but sample requirements remain unchanged currently.
MEMORANDUM Originating Department Chemical Pathology Issued By: Issued To: Subject: Details: Dr. Shari Srinivasan All Laboratory Service Users Change in Chemical Pathology Analysers Dear Colleague, As
M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017
M.D.IPA, M.D.IPA Preferred, Optimum Choice and Optimum Choice Preferred STAT Laboratory List Revised Jan. 5, 2017 If laboratory results are required on a STAT basis, the designated commercial medical laboratory
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION LANCET KENYA LIMITED UPPERHILL NAIROBI LABORATORY Co. Reg. No.: C168507 Facility Accreditation Number: is a South African National Accreditation System accredited laboratory
Excellence and confidence
Thermo Scientific System Reagents Fully supported and guaranteed, CE marked system solutions Streamlined supply and support Maximum stability and reduced waste Standardised performance in External Quality
Inspector's Accreditation Unit Activity Menu
01/12/20XX 15:58:57 Laboratory Accreditation Program Page 1 of 9 CHEMISTRY 1501 ALT, serum/plasma 1502 Albumin, serum/plasma 1504 Alkaline phosphatase, serum/plasma 1506 Amylase, serum/plasma 1508 Bilirubin,
SCOPE OF ACCREDITATION TO ISO 15189:2012. SPECTRA, EAST LABORATORY 8 King Road Rockleigh, NJ Stylianos Lomvardias, M.D.
COPE OF ACCREDITATION TO IO 15189:2012 PECTRA, EAT LABORATORY 8 King Road Rockleigh, NJ 07647 tylianos Lomvardias, M.D. CLINICAL Valid To: eptember 28, 2018 Certificate Number: 3024.01 In recognition of
PROFILES MENU. Page no. 9 Page no. 8 Page no. 7 Page no. 6 Page no. 5. Page no. 2. Page no. 4 Page no. 3
Health Profiles PROFILES MENU Page no. 1 Page no. 2 Page no. 4 Page no. 3 1 Basic Metabolic Panel (BMP) 2 Liver Function Tests (LFT) 3 Comprehensive Metabolic Panel (CMP) 4 Lipid Profile 5 Chem 7 Panel
Epic Labs Orderable As STAT PRIORITY As of 06/22/2016
ABG+HB(CORDARTERIAL) - BABY A ABG+HB(CORD ARTERIAL)- BABY B ABG+HB(CORD ARTERIAL)- BABY C ACETAMINOPHEN LEVEL ALANINE AMINOTRANSFERASE (ALT) ALBUMIN, FLUID ALBUMIN, PLEURAL FLUID ALBUMIN, SYNOVIAL FLUID
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
REAGENTS THE HIGHEST QUALITY RANGE OF ROUTINE AND NOVEL REAGENTS
THE HIGHEST QUALITY RANGE OF ROUTINE AND NOVEL REAGENTS Advancing Biochemistry Testing for Laboratories CONTENTS 01 06 43 46 53 55 60 BENEFITS OF RANDOX REAGENTS REAGENTS - RANDOX THIRD PARTY REAGENTS
CERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION In terms of section 22(2) (b) of the Accreditation for Conformity Assessment, Calibration and Good Laboratory Practice Act, 2006 (Act 19 of 2006), read with sections 23(1),
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Hammersmith Medicines Research Limited Cumberland Avenue Park Royal London NW10 7EW Contact: Juan Naveda Tel: +44 (0) 20 8961 4130 Fax: +44
Traceability in External Quality Assessment: How Weqas ensures traceability in EQA and stresses its importance to users. David Ducroq.
Traceability in External Quality Assessment: How Weqas ensures traceability in EQA and stresses its importance to users David Ducroq Weqas Unit 6, Parc Tŷ Glas Llanishen Cardiff UK www.weqas.com Programme
PATHOLOGY SPECIMEN TUBES QUICK REFERENCE GUIDE : Edition Expires July 2013
PATHOLOGY SPECIMEN TUBES QUICK REFERENCE GUIDE : 2012 2013 Edition Expires July 2013 FOR THE MOST UP TO DATE INFORMATION AND FOR TESTS THAT ARE NOT LISTED HERE PLEASE CHECK THE INTRANET SITE AT: http://rhhlas26/path_tests/lab_default.asp
PRICE LIST RELIABLE ACCURATE COST EFFECTIVE. American Technology Made in India For India. W.E.F April 2018
PRICE LIST W.E.F April 2018 RELIABLE ACCURATE COST EFFECTIVE American Technology Made in India For India +91-44-22541131 www.athenesedx.com info@athenesedx.com Code OnSite Rapid Tests R0061C R0062C R0062C
General Chemistry Scheme Guide
General Chemistry Scheme Guide Copyright WEQAS. All rights reserved. No part of this document may be reproduced or utilised in any form without permission from WEQAS Contents. Scheme details and repertoire.....
Online catalog
This catalog contains information about tests performed at Green Clinic Laboratory. For samples to be sent to Quest Diagnostics or any other reference lab please contact the Green Clinic Laboratory (318-251-6378)
PLUNGER ( ) Not applicable. Field Safety Corrective Action (FSCA)
Urgent Field Safety Notice SBN-CPS-2018-002 CPS / Serum Work Area Version 4 xx-mar-2018 cobas e 801 syringe plunger issue Product Name Affected Instrument Part GMMI / Part No cobas 8000 modular analyzer
External Quality Assessment for Calibration Laboratories in Laboratory Medicine - RELA -
External Quality Assessment for Calibration Laboratories in Laboratory Medicine - RELA - Anja Kessler Bonn, Germany 1 RELA Surveys www.dgkl-rfb.de 2 RELA Annual Process Each participant receives two different
Thermo Scientific System Reagents Excellence in Clinical Chemistry
Thermo Scientific System Reagents Excellence in Clinical Chemistry Part of Thermo Fisher Scientific Covering over 150 CE marked products, Thermo Scientific system reagents are specifically developed and
Bureau of Laboratory Quality Standards Page 1 of 13
Clinical Chemistry 1. Lithium Heparin Plasma Glucose Glucose Hexokinase : Cobas c6000,c8000 2. Lithium Heparin Plasma BUN Urease,Kinetic : Cobas c6000,c8000 3. Lithium Heparin Plasma Creatinine Enzymatic
Annex to the Accreditation Certificate D-ML according to ISO 15189:2012
Deutsche Akkreditierungsstelle GmbH according to ISO 15189:2012 Period of validity: 31.10.2016 to 30.10.2021 Date of issue: 31.10.2016 Holder of certificate: Medlab Ghana Limited 17 Ridge Road, Roman Ridge,
Test Result Reference Range Flag
Date of Last Result Test Result Reference Range Flag Dec 07, 2016 25-Hydroxy Vitamin D Total 53 ng/ml 30-100 ng/ml Activated Partial Thromboplast Time Alanine Aminotransferase (ALT/SGPT) 25 sec 24-35 sec
Code TEST SPECIMEN REQUIREMENT TAT Referral centre. 1 week BP GM (Specimen stability: 2-8 C for 48 hours) 3240 Anti-ds DNA 3 ml Plain Blood/Serum
B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause
Questionnaire. Traceability in EQA. Traceability
Questionnaire in EQA QUESTIONNAIRE ON TRACEABILITY QUESTIONNAIRE ON TRACEABILITY GENERAL INFORMATION Name EQA organisation Country Specify the total number of measurands in the schemes of your EQA organisation
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Tameside and Glossop Integrated Care NHS Foundation Trust Department of Blood Sciences Tameside General Hospital New Fountain House Ashton-under-Lyne
A007 Allergy Basic Profile (28 parameters) 5 ml Plain Blood/Serum week BPGM
B.P. CLINICAL LAB SDN. BHD. ESOTERIC TEST LIST Note: For campaign profile, please notify processing lab 3 weeks in advanced for reagent and consumables preparation. Failure to pre-notify lab will cause
Biochemistry Adult Reference Ranges
Certified correct on 28/06/2016 Biochemistry Adult Reference Ranges Test Reference range Units Reference range from Traceable to standard reference material Albumin 35 50 g/l Pathology IRMM ERM-DA470k/IFCC
MAGLUMI 1000 MAGLUMI 1000
MAGLUMI 1000 Outstanding Technology Power of MAGLUMI Chemiluminescence Immunoassay (CLIA) System CLIA uses two important technologies, one is labeling technology which determines reaction mode; and the
ONTARIO ND PRICE LIST
ONTARIO ND PRICE LIST Note: There is a $7.76 per requisition documentation fee. Prices valid only in Ontario. PANEL Healthy Living Assessment Panel $100.00 Enhanced Healthy Living Assessment Panel $180.00
Thermo Scientific Konelab System Reagents For convenient and reliable analysis
Thermo Scientific Konelab System Reagents For convenient and reliable analysis Part of Thermo Fisher Scientific Thermo Scientific Konelab system reagents ensure the high quality analysis results Easy-to-use